MCD vs PFE: Which Is the Better Buy?
Side-by-side comparison of McDonald's Corporation and Pfizer Inc. โ fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-18.
McDonald's Corporation ยท Consumer Cyclical
$252.78
+40.7% upside to fair value
Med Conviction
Grade A
High Quality
VS
Pfizer Inc. ยท Healthcare
$27.64
+12.0% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
MCD has more upside to fair value
(+40.7%).
These are model outputs โ not personalized investment advice.
See all research โ
Valuation & Fundamentals
| Metric |
MCD |
PFE |
| Current Price |
$252.78 |
$27.64 |
| Fair Value Estimate |
$355.71 |
$30.94 |
| Upside to Fair Value |
+40.7%
|
+12.0%
|
| Market Cap |
$179.6B |
$157.5B |
| Forward P/E |
โ
|
โ
|
| EV / EBITDA |
15.5x
|
17.4x
|
| Price / Sales |
6.5x
|
2.5x
|
| Price / FCF |
23.1x
|
14.3x
|
| Revenue Growth YoY |
+3.8%
|
+2.6%
|
| Gross Margin |
57.4%
|
71.3%
|
| Operating Margin |
45.8%
|
25.1%
|
| Return on Equity |
-561.2%
|
4.9%
|
| Dividend Yield |
2.94% |
6.22% |
| FCF Yield |
4.32%
|
6.97%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
McDonald's operates a globally scaled, approximately 95% franchised restaurant system with 46,028 restaurants in more than 100 countries, combining a powerful consumer brand, real-estate-backed franchise economics, supplier scale and digital loyalty reach. Business quality is high despite meaningful leverage: TTM gross, operating and net margins are 57.4%, 45.8% and 31.7%, respectively, while loyโฆ
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating โฆ
Accumulation Zones
| Metric |
MCD |
PFE |
| Zone Low |
$266.78 |
$23.21 |
| Zone High |
$302.35 |
$26.30 |
| In Buy Zone? |
Yes
|
No
|